港迪技术：2025年前三季度净利润约4339万元，同比下降25.24%

Group 1 - Company Hongdi Technology (SZ 301633) reported Q3 performance with revenue of approximately 361 million yuan, a year-on-year decrease of 3.3% [1] - The net profit attributable to shareholders was about 43.39 million yuan, down 25.24% year-on-year [1] - Basic earnings per share were 0.78 yuan, reflecting a year-on-year decline of 43.88% [1] Group 2 - As of the report, Hongdi Technology's market capitalization stands at 4.2 billion yuan [2] - The Chinese innovative drug sector has seen overseas licensing sales reach 80 billion USD this year [2] - There is a contrast in the biopharmaceutical secondary market's heat versus the cooling fundraising in the primary market [2]